Search Results for 'patients refractory'
patients refractory published presentations and documents on DocSlides.
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Super-refractory Status Epilepticus
by sherrill-nordquist
Utku Uysal, M.D. M.S.. Seizure: . “a . transien...
Denver ascites shunts For patients with refractory ascites For patients with refractory ascites consider peritoneovenous shunting PVS with the Denver shunt
by briana-ranney
A specially designed silicone medical device cons...
PERAMPANEL AS PROPHYLAXIS TREATMENT IN REFRACTORY CHRONIC MIGRAI
by tracy
Objective: Chronic migraine is a disabling disease...
x0000x0000 xAttxachexd xBottxom xBBoxx
by evans
Chimeric Antigen Receptor Tcell TherapyClinical Gu...
DR: Hussein Sabbagh Oncologist / Radiotherapist
by connor899
Epidemiology . https://seer.cancer.gov/statfacts/h...
Improving Therapy Outcomes in Relapsed/Refractory
by celsa-spraggs
Hodgkin Lymphoma. Program Objectives. Brentuximab...
@ BorawskiKristy Refractory Overactive Bladder
by iris
in Men. Kristy M. Borawski, MD. Associate Professo...
Case Discussion A 64-year old woman diagnosed with monoclonal
by faustina-dinatale
Case Discussion A 64-year old woman diagnosed wit...
Treatment Of Later Relapse/ Chemo-Resistant
by ida
Diffuse Large B Cell Lymphoma. Foroud. . shahbazi...
Treatment of refractory patients with autoimmune liver diseases
by ashley
Iskren. . Kotzev. Medical University, Varna. Л�...
Hodgkin Lymphoma in Children and
by maddoxjustin
Adolescents. Introduction . Hodgkin Lymphoma (HL...
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
by botgreat
Lisocabtagene. . Maraleucel. in Relapsed/Refract...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Introduction Sacral nerve stimulation is an accepted treatment option for refractory over active b
by alexa-scheidler
nonobstructive. urinary retention (UR). Over ti...
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki
by cesar673
+. Peripheral T-Cell Lymphoma: A Phase 2 Study (L...
Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref
by willow
Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...
The Pump Paradox: To Pump or Not Too Pump?
by Dollface
Amar Patel, MD. Colorado Pain society 2. ND. Ann...
@ BorawskiKristy Refractory Overactive Bladder in Men
by summer
Kristy M. Borawski. Associate Professor. Universit...
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...
Once Weekly Selinexor Carfilzomib and Dexamethasone XKd in Heavily Pre
by layla
Cristina Gasparetto MD1 Gary J Schiller MD2 Sascha...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...